We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA RELEASES TRIO OF DRAFT GUIDANCES ON RISK MANAGEMENT
FDA RELEASES TRIO OF DRAFT GUIDANCES ON RISK MANAGEMENT
May 4, 2004
Following up on risk management concept papers issued last spring, the FDA yesterday released three draft guidances to help drug manufacturers achieve more benefits from drug and biologic products while minimizing their risks.